Paper33767178
Combination therapy protects macaques against advanced Marburg virus disease.
Cross RW and 15 others. Nat Commun, 2021. Cited by 71 papers, by iCite.
Cite this record
ConductScience Library. Combination therapy protects macaques against advanced Marburg virus disease. Papers, record 33767178. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33767178
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenosine Monophosphate | Major topic |
| Alanine | Major topic |
| Antibodies, Monoclonal | Major topic |
| Antibodies, Viral | Major topic |
| Marburg Virus Disease | Major topic |
| Marburgvirus | Major topic |
| Animals | |
| Disease Models, Animal | |
| Drug Therapy, Combination | |
| Macaca mulatta | |
| Viral Load |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| U19 AI142785 | NIAID NIH HHS | United States | U19AI142785 | PubMed and NIH | NIH RePORTER |
| UC7 AI094660 | NIAID NIH HHS | United States | UC7AI094660 | PubMed and NIH | NIH RePORTER |
References47
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32821939 | Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial. | JAMA | 2020 | https://conductscience.org/library/papers/32821939 | PubMed |
| 2 | 22411795 | Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease. | Proc Natl Acad Sci U S A | 2012 | https://conductscience.org/library/papers/22411795 | PubMed |
| 3 | 25723164 | Mechanism of human antibody-mediated neutralization of Marburg virus. | Cell | 2015 | https://conductscience.org/library/papers/25723164 | PubMed |
| 4 | 23035224 | Inhibition of Marburg virus budding by nonneutralizing antibodies to the envelope glycoprotein. | J Virol | 2012 | https://conductscience.org/library/papers/23035224 | PubMed |
| 5 | 32459919 | Remdesivir for 5 or 10 Days in Patients with Severe Covid-19. | N Engl J Med | 2020 | https://conductscience.org/library/papers/32459919 | PubMed |
| 6 | 32054787 | Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection. | Proc Natl Acad Sci U S A | 2020 | https://conductscience.org/library/papers/32054787 | PubMed |
| 7 | 16973752 | Rapid high-yield expression of full-size IgG antibodies in plants coinfected with noncompeting viral vectors. | Proc Natl Acad Sci U S A | 2006 | https://conductscience.org/library/papers/16973752 | PubMed |
| 8 | 24168292 | Antibody discovery: sourcing of monoclonal antibody variable domains. | Curr Drug Discov Technol | 2014 | https://conductscience.org/library/papers/24168292 | PubMed |
| 9 | 26159721 | Isolation and Characterization of Broad and Ultrapotent Human Monoclonal Antibodies with Therapeutic Activity against Chikungunya Virus. | Cell Host Microbe | 2015 | https://conductscience.org/library/papers/26159721 | PubMed |
| 10 | 32516797 | Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2. | Nature | 2020 | https://conductscience.org/library/papers/32516797 | PubMed |
| 11 | 25143366 | Marburg virus infection in nonhuman primates: Therapeutic treatment by lipid-encapsulated siRNA. | Sci Transl Med | 2014 | https://conductscience.org/library/papers/25143366 | PubMed |
| 12 | 28381540 | Therapeutic treatment of Marburg and Ravn virus infection in nonhuman primates with a human monoclonal antibody. | Sci Transl Med | 2017 | https://conductscience.org/library/papers/28381540 | PubMed |
| 13 | 23558974 | Principles for valid histopathologic scoring in research. | Vet Pathol | 2013 | https://conductscience.org/library/papers/23558974 | PubMed |
| 14 | 32719371 | Prior vaccination with rVSV-ZEBOV does not interfere with but improves efficacy of postexposure antibody treatment. | Nat Commun | 2020 | https://conductscience.org/library/papers/32719371 | PubMed |
| 15 | 31980636 | Isolation of Angola-like Marburg virus from Egyptian rousette bats from West Africa. | Nat Commun | 2020 | https://conductscience.org/library/papers/31980636 | PubMed |
| 16 | 19785757 | Large serological survey showing cocirculation of Ebola and Marburg viruses in Gabonese bat populations, and a high seroprevalence of both viruses in Rousettus aegyptiacus. | BMC Infect Dis | 2009 | https://conductscience.org/library/papers/19785757 | PubMed |
| 17 | 29939296 | Postexposure Efficacy of Recombinant Vesicular Stomatitis Virus Vectors Against High and Low Doses of Marburg Virus Variant Angola in Nonhuman Primates. | J Infect Dis | 2018 | https://conductscience.org/library/papers/29939296 | PubMed |
| 18 | 18258034 | Studies of reservoir hosts for Marburg virus. | Emerg Infect Dis | 2007 | https://conductscience.org/library/papers/18258034 | PubMed |
| 19 | 30629918 | A Two-Antibody Pan-Ebolavirus Cocktail Confers Broad Therapeutic Protection in Ferrets and Nonhuman Primates. | Cell Host Microbe | 2019 | https://conductscience.org/library/papers/30629918 | PubMed |
| 20 | 23055920 | Seasonal pulses of Marburg virus circulation in juvenile Rousettus aegyptiacus bats coincide with periods of increased risk of human infection. | PLoS Pathog | 2012 | https://conductscience.org/library/papers/23055920 | PubMed |
Cited by57
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 71 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42554640 | Plasma concentrations of nirmatrelvir and molnupiravir required for inhibition of SARS-CoV-2 replication differ between rhesus macaques and humans. | Antimicrob Agents Chemother | 2026 | https://conductscience.org/library/papers/42554640 | PubMed |
| 42249100 | Bundibugyo virus-perspectives for the current outbreak. | Npj Viruses | 2026 | https://conductscience.org/library/papers/42249100 | PubMed |
| 42145049 | Small Molecule Inhibition of Mononegavirales RNA Polymerases. | J Med Virol | 2026 | https://conductscience.org/library/papers/42145049 | PubMed |
| 42115643 | Endolysosomal trafficking regulator SH-BC-893 inhibits coronavirus entry in vitro and in vivo. | Sci Rep | 2026 | https://conductscience.org/library/papers/42115643 | PubMed |
| 42081574 | Characterization of atypical Ebola virus disease in ferrets. | PLoS Pathog | 2026 | https://conductscience.org/library/papers/42081574 | PubMed |
| 42076078 | Achievements and Challenges in Therapy and Vaccines Development of Viral Hemorrhagic Fevers: An Up-to-Date Review. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42076078 | PubMed |
| 41995349 | Clinical trial simulation of antiviral drugs. | J Virol | 2026 | https://conductscience.org/library/papers/41995349 | PubMed |
| 41648181 | Characterization of Atypical Ebola Virus Disease in Ferrets. | bioRxiv | 2026 | https://conductscience.org/library/papers/41648181 | PubMed |
| 41501462 | Oral 4'-fluorouridine rescues nonhuman primates from advanced Lassa fever. | Nature | 2026 | https://conductscience.org/library/papers/41501462 | PubMed |
| 41377211 | Post-exposure prevention in Marburg virus outbreaks: potential role of remdesivir in emergency response. | Ann Med Surg (Lond) | 2025 | https://conductscience.org/library/papers/41377211 | PubMed |
| 41225006 | Potent neutralization of Marburg virus by a vaccine-elicited antibody. | Nature | 2026 | https://conductscience.org/library/papers/41225006 | PubMed |
| 40898685 | Increasing Occurrence of Marburg Virus Outbreaks in Africa: Risk Assessment for Public Health. | Microb Biotechnol | 2025 | https://conductscience.org/library/papers/40898685 | PubMed |
| 40732724 | Thirteen-Year Sequelae of Marburg Virus Disease Survival: Persistent Cardiometabolic, Immunometabolic, and Haematological Alterations in the Absence of Psychological Morbidity. | Pathogens | 2025 | https://conductscience.org/library/papers/40732724 | PubMed |
| 40728975 | Valorization of a Natural Compound Library in Exploring Potential Marburg Virus VP35 Cofactor Inhibitors via an In Silico Drug Discovery Strategy. | Curr Issues Mol Biol | 2025 | https://conductscience.org/library/papers/40728975 | PubMed |
| 40608418 | Marburg virus glycoprotein mRNA vaccine is more protective than a virus-like particle-forming mRNA vaccine. | J Clin Invest | 2025 | https://conductscience.org/library/papers/40608418 | PubMed |
| 40575643 | Marburg virus disease: Emerging threat, pathogenesis, and global public health strategies. | World J Virol | 2025 | https://conductscience.org/library/papers/40575643 | PubMed |
| 40573427 | Pharmacokinetics and Metabolism of Broad-Spectrum Antivirals Remdesivir and Obeldesivir with a Consideration to Metabolite GS-441524: Same, Similar, or Different? | Viruses | 2025 | https://conductscience.org/library/papers/40573427 | PubMed |
| 40337393 | Therapeutic advances in Marburg virus disease: from experimental treatments to vaccine development. | Ann Med Surg (Lond) | 2025 | https://conductscience.org/library/papers/40337393 | PubMed |
| 40333077 | Emerging Strategies and Progress in the Medical Management of Marburg Virus Disease. | Pathogens | 2025 | https://conductscience.org/library/papers/40333077 | PubMed |
| 40291443 | In silico drug repurposing of potential antiviral inhibitors targeting methyltransferase (2'-O-MTase) domain of Marburg virus. | In Silico Pharmacol | 2025 | https://conductscience.org/library/papers/40291443 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ALB | 213 | PubTator's text mining | https://conductscience.org/library/genes/213 | NCBI Gene |
| CRP | 1401 | PubTator's text mining | https://conductscience.org/library/genes/1401 | NCBI Gene |
| GGT1 | 2678 | PubTator's text mining | https://conductscience.org/library/genes/2678 | NCBI Gene |
| GPT | 2875 | PubTator's text mining | https://conductscience.org/library/genes/2875 | NCBI Gene |
| PUDP | 8226 | PubTator's text mining | https://conductscience.org/library/genes/8226 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33767178
GET https://conductscience.org/api/papers/v1/33767178/references?page=2